Diabetes & CVD: Time for a multifactorial approach
In recent years, new insights into the CV risk associated with diabetes have resulted in a new management approach of T2DM. Prof. Deanfield explains the rationale of a multifactorial approach.
Video navigation menu
- Diabetes is associated with substantial CV risk, which is already present before diagnosis 0:25
- Management of diabetes and the associated CV risk requires a multifactorial approach 2:57
- How should CV risk reduction in diabetes be approached? 4:46
- Too intensive glucose-lowering therapy may cause harm 7:14
- New strategies to lower blood glucose have turned out to be real game changers 8:25
This lecture was part of a CME accredited symposium: "Outcomes of GLP-1 RA in Diabetes & CVD: What are the key opportunities for cardiology practice?", held during ESC 2018 in Munich, Germany.
Prof John E Deanfield, MD - cardiologist, University College London, London, UK
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk.
This is available as accredited online CME for members. Click the button below to enroll:Enroll